HUT53528A - Process for production of having antiviral effectg, well suluable in water stabil cristallic salts of 2',3' dideozoxiinozin- monohidrat, 2',3'-didezoxi-2'3'-didohydrotimidin monohydrate and 2',3' didezoxi-2'-fluor-inosine-hemihydrate and medical compositions containing these salts - Google Patents

Process for production of having antiviral effectg, well suluable in water stabil cristallic salts of 2',3' dideozoxiinozin- monohidrat, 2',3'-didezoxi-2'3'-didohydrotimidin monohydrate and 2',3' didezoxi-2'-fluor-inosine-hemihydrate and medical compositions containing these salts

Info

Publication number
HUT53528A
HUT53528A HU903038A HU303890A HUT53528A HU T53528 A HUT53528 A HU T53528A HU 903038 A HU903038 A HU 903038A HU 303890 A HU303890 A HU 303890A HU T53528 A HUT53528 A HU T53528A
Authority
HU
Hungary
Prior art keywords
salts
didezoxi
antiviral
suluable
monohidrat
Prior art date
Application number
HU903038A
Other languages
English (en)
Other versions
HU903038D0 (en
HU206628B (en
Inventor
Arthur Murray Kaplan
Kevin Robert Perrone
Ballard Joseph Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HU903038D0 publication Critical patent/HU903038D0/hu
Publication of HUT53528A publication Critical patent/HUT53528A/hu
Publication of HU206628B publication Critical patent/HU206628B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
HU903038A 1989-05-15 1990-05-15 Process for producing antiviral, watersoluble, stabile, christalline salts of 2',3'-dideoxyinozine-monohydate, 2,'3'-2'-fluoro-inozine-hemihydrate and pharmaceutical compositions containing them HU206628B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35206589A 1989-05-15 1989-05-15
US51426190A 1990-05-01 1990-05-01

Publications (3)

Publication Number Publication Date
HU903038D0 HU903038D0 (en) 1990-09-28
HUT53528A true HUT53528A (en) 1990-11-28
HU206628B HU206628B (en) 1992-12-28

Family

ID=26997373

Family Applications (1)

Application Number Title Priority Date Filing Date
HU903038A HU206628B (en) 1989-05-15 1990-05-15 Process for producing antiviral, watersoluble, stabile, christalline salts of 2',3'-dideoxyinozine-monohydate, 2,'3'-2'-fluoro-inozine-hemihydrate and pharmaceutical compositions containing them

Country Status (16)

Country Link
EP (1) EP0398230B1 (hu)
KR (1) KR970001160B1 (hu)
CN (2) CN1027896C (hu)
AT (1) ATE162528T1 (hu)
AU (1) AU617614B2 (hu)
BG (1) BG60517B1 (hu)
DE (1) DE69031962T2 (hu)
DK (1) DK0398230T3 (hu)
EG (1) EG19154A (hu)
ES (1) ES2113851T3 (hu)
FI (1) FI95269C (hu)
GR (1) GR3025984T3 (hu)
HU (1) HU206628B (hu)
IE (1) IE81107B1 (hu)
NO (2) NO174102C (hu)
PT (1) PT94040B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO920714L (no) * 1991-03-01 1992-09-02 Bristol Myers Squibb Co Tetrahydrofuran-mellomprodukt
US5221611A (en) * 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
DE69421721T2 (de) * 1994-01-07 2000-04-27 Merrell Pharma Inc (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat
WO2006007448A2 (en) * 2004-06-17 2006-01-19 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions and related methods of use
US8445669B2 (en) 2008-04-10 2013-05-21 Hamari Chemicals, Ltd. Production process of ethynylthymidine compounds from 5-methyluridine as a starting material

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
ZA891076B (en) * 1988-02-16 1990-10-31 Lilly Co Eli 2',3'-dideoxy-2',2'-difluoronucleosides
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
CN1027896C (zh) 1995-03-15
EP0398230A3 (en) 1991-06-26
NO176609C (no) 1995-05-03
DK0398230T3 (da) 1998-09-21
HU903038D0 (en) 1990-09-28
GR3025984T3 (en) 1998-04-30
FI95269C (fi) 1996-01-10
NO933367D0 (no) 1993-09-22
NO902148L (no) 1990-11-16
IE901734L (en) 1990-11-15
NO176609B (no) 1995-01-23
EP0398230B1 (en) 1998-01-21
DE69031962T2 (de) 1998-09-17
DE69031962D1 (de) 1998-02-26
ATE162528T1 (de) 1998-02-15
NO174102C (no) 1994-03-16
EG19154A (en) 1994-09-29
PT94040A (pt) 1991-01-08
NO902148D0 (no) 1990-05-15
ES2113851T3 (es) 1998-05-16
AU5501190A (en) 1990-11-15
HU206628B (en) 1992-12-28
CN1109755A (zh) 1995-10-11
PT94040B (pt) 1996-12-31
AU617614B2 (en) 1991-11-28
NO174102B (no) 1993-12-06
NO933367L (no) 1990-11-16
EP0398230A2 (en) 1990-11-22
CN1057443C (zh) 2000-10-18
FI902360A0 (fi) 1990-05-11
IE81107B1 (en) 2000-03-08
FI95269B (fi) 1995-09-29
KR970001160B1 (ko) 1997-01-29
CN1047676A (zh) 1990-12-12
BG60517B1 (bg) 1995-07-28
KR900017591A (ko) 1990-12-19

Similar Documents

Publication Publication Date Title
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
ES2057016T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo (3.2.0) hept-2-eno-2-carboxilico.
HU9401943D0 (en) Process for producing amide and urea derivatives and compositions containing them
HU903830D0 (en) Herbicide and biological regulator preparatives containing derivatives of salicylic aldehyde and salicylic acid as well as their sulphury analogues furthermore process for producing the active agents
JPS6425777A (en) Organic salt of physostigmine
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
GB8607921D0 (en) 3,4-disubstituted-2-azetidinone derivatives
EP0314098A3 (en) Imide derivatives, their production and use
EP0288969A3 (en) Antiulcer composition
HUT52099A (en) Process for producing antiviral tetrahydroimidazo/1,4/benzodiazepin-2-one derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT53528A (en) Process for production of having antiviral effectg, well suluable in water stabil cristallic salts of 2',3' dideozoxiinozin- monohidrat, 2',3'-didezoxi-2'3'-didohydrotimidin monohydrate and 2',3' didezoxi-2'-fluor-inosine-hemihydrate and medical compositions containing these salts
HU901193D0 (en) Process for protection against phytopathogenic bacteria using phosphonic acid derivatives
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
GR3006438T3 (hu)
MY116824A (en) Antivaral,highly water soluble,stable,crystalline salts of 2'',3''-dideoxyinosine monohydrate,2'',3''-dideoxy-2'' ,3''-didehydrothymidine monohydrate and 2'',3''-dideoxy-2''-fluoroinosine hemihydrate
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
ZA896741B (en) 3-piperidinyl-indazole derivatives
EP0381114A3 (en) Exo-3',4'-0-benzylidene-3"-demethylchartreusin and its salts
EP0421668A3 (en) 1,4-dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
HUT38607A (en) Process for producing phenyl-ethyl-amino-propiophenone derivatives and pharmaceutical composition containing them as active agents
IL86136A (en) Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees